surfkast
4 minutes ago
Pump and dump?
Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies
LAS VEGAS, NV – January 23rd, 2025 – Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI), an innovative topical pharmaceutical research and development company,
today announces